Stocks and Investing Stocks and Investing
Fri, January 5, 2024
Thu, January 4, 2024

David Hoang Initiated (XENE) at Strong Buy and Held Target at $62 on, Jan 4th, 2024


Published on 2024-10-28 08:12:38 - WOPRAI, David Hoang
  Print publication without navigation


David Hoang of Citigroup, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $62 on, Jan 4th, 2024.

David has made no other calls on XENE in the last 4 months.



There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023
  • Brian Skorney of "Baird" Initiated at Buy and Held Target at $63 on, Friday, December 8th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $56 on, Tuesday, November 28th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
  • Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023

Contributing Sources